Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42551-42600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05753722
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
PHASE1Recruiting
270 participants
Started: Mar 3, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor9 locations
NCT05768919
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 3, 2023 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT05754307
A Closed Surgical Technique vs Papilla Preservation Techniques
NARecruiting
44 participants
Started: Mar 3, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05597735
Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease
PHASE3Recruiting
480 participants
Started: Mar 3, 2023 · Completed: Nov 30, 2026
2 conditions4 sponsors12 locations
NCT05711173
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NARecruiting
150 participants
Started: Mar 3, 2023 · Completed: Mar 31, 2027
4 conditions1 sponsor7 locations
NCT05501899
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
EARLY_PHASE1Recruiting
20 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2024
2 conditions2 sponsors2 locations
NCT05408845
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
PHASE2Recruiting
146 participants
Started: Mar 3, 2023 · Completed: Jul 31, 2028
5 conditions2 sponsors132 locations
NCT05712746
Samtasu Post-marketing General Drug Use-results Survey in Patients with Volume Overload in Heart Failure.
N/ARecruiting
1,600 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06306248
Immune Activation, Neural Plasticity and Depression
N/ARecruiting
60 participants
Started: Mar 3, 2023 · Completed: May 9, 2025
3 conditions1 sponsor1 location
NCT07162051
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
PHASE2Recruiting
28 participants
Started: Mar 3, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05691478
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
PHASE2/PHASE3Recruiting
1,122 participants
Started: Mar 3, 2023 · Completed: Mar 20, 2030
4 conditions1 sponsor156 locations
NCT05640102
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
N/ARecruiting
111 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor11 locations
NCT05737797
Non-Invasive Diagnosis of Endometrial Cancer
NARecruiting
100 participants
Started: Mar 3, 2023 · Completed: Oct 10, 2024
1 condition1 sponsor1 location
NCT06375057
Relationship Between Acute Phase Markers and Post-operative Pain in Laparoscopic Cholecystectomy: An Observational Study
N/ARecruiting
54 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06416995
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes
N/ARecruiting
88 participants
Started: Mar 3, 2023 · Completed: Dec 30, 2024
5 conditions1 sponsor1 location
NCT06291675
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
N/ARecruiting
50 participants
Started: Mar 3, 2023 · Completed: Mar 3, 2033
2 conditions1 sponsor1 location
NCT05503173
Telehealth for Pain and Unhealthy Drinking Among PLWH
NARecruiting
385 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT06519500
Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery
N/ARecruiting
40 participants
Started: Mar 3, 2023 · Completed: Nov 3, 2026
1 condition1 sponsor1 location
NCT06301282
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
N/ARecruiting
30 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05586074
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
PHASE3Recruiting
324 participants
Started: Mar 3, 2023 · Completed: Jun 14, 2027
1 condition1 sponsor1 location
NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
N/ARecruiting
100 participants
Started: Mar 3, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05556824
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
PHASE2Recruiting
247 participants
Started: Mar 3, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors17 locations
NCT05517928
A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis
NARecruiting
30 participants
Started: Mar 3, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05570812
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
PHASE2Recruiting
120 participants
Started: Mar 3, 2023 · Completed: Jan 31, 2028
3 conditions3 sponsors1 location
NCT05704881
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
N/ARecruiting
240 participants
Started: Mar 3, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors2 locations
NCT05772364
High- Versus Low-calcium Water for Bone Health
NARecruiting
41 participants
Started: Mar 2, 2023 · Completed: May 31, 2026
5 conditions1 sponsor1 location
NCT05660161
This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
NARecruiting
20 participants
Started: Mar 2, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT04128189
Shingrix in Renal Transplant Recipients
PHASE3Recruiting
132 participants
Started: Mar 2, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05147649
Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome
NARecruiting
70 participants
Started: Mar 2, 2023 · Completed: Jul 2, 2026
1 condition1 sponsor1 location
NCT05477264
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
PHASE2Recruiting
38 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05911464
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
PHASE1Recruiting
248 participants
Started: Mar 2, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05779345
Stability of Short Implants Versus Standard Blx Implants With Internal Sinus Floor Elevation in Posterior Maxilla
NARecruiting
42 participants
Started: Mar 2, 2023 · Completed: Jul 2, 2025
1 condition1 sponsor1 location
NCT05738005
Dietary Reporting in the Amyloidoses
NARecruiting
40 participants
Started: Mar 2, 2023 · Completed: Nov 21, 2025
1 condition1 sponsor1 location
NCT05450185
Filter Lifespan in Continuous Renal Replacement Therapy
N/ARecruiting
600 participants
Started: Mar 2, 2023 · Completed: Aug 31, 2025
3 conditions2 sponsors5 locations
NCT05947695
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer
NARecruiting
100 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2029
2 conditions1 sponsor1 location
NCT05660382
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
PHASE3Recruiting
100 participants
Started: Mar 2, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor7 locations
NCT05645276
A Study of AK129 in Patients With Advanced Malignant Tumors
PHASE1Recruiting
182 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05489588
The GORE® VIAFORT Vascular Stent Iliofemoral Study
NARecruiting
165 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2031
10 conditions1 sponsor24 locations
NCT05496829
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
NARecruiting
350 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05386914
Short Term Sirolimus Treatment and MRI of the Brain and Lungs
PHASE1Recruiting
205 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05738434
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
PHASE2Recruiting
188 participants
Started: Mar 2, 2023 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT05493605
Cardiac Involvement in Wilson's Disease
NARecruiting
150 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06590506
High Definition Medicine for Solid Tumors Oncology
N/ARecruiting
300 participants
Started: Mar 2, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor9 locations
NCT05142787
Magseed Pro(R)/ Sentimag(R) Gen3
NARecruiting
224 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT05716282
Estimation of Neuromuscular Recovery - a Validation Study
N/ARecruiting
100 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06947915
Co-producing a Novel Model an Outcome Framework for the Implementation of Falls Management in Care Home Settings.
N/ARecruiting
31 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05284955
Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)
PHASE4Recruiting
60 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Mar 2, 2023 · Completed: Mar 2, 2026
9 conditions2 sponsors1 location
NCT06462703
Tablet-based Application for Cognitive Therapy
NARecruiting
200 participants
Started: Mar 2, 2023 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05741957
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
NARecruiting
300 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location